Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durability
ContributorsCsaki Huttner, Angela; Agnandji, Selidji Todagbe; Hooper, Jay W.; Kwilas, Steve; Ricks, Keersten; Clements, Tamara L.; Jonsdottir, Hulda R.; Nakka, Sravya Sowdamini; Züst, Roland; Medaglini, Donata; Harandi, Ali M.; Siegrist, Claire-Anne; Krishna, Sanjeev; Brosnahan, Jessica S.; Addo, Marylyn M.; Becker, Stephan; Krahling, Verena; Kieny, Marie-Paule; Moorthy, Vasee; Fast, Patricia; Savarese, Barbara; Lapujade, Olivier; Agnandji, Selidji Todagbe; Ahmed, Rafi; Anderson, Jenna; Auderset, Floriane; Bejon, Philip; Borgianni, Luisa; Ciabattini, Annalisa; Engler, Olivier; Haks, Marie lle C.; Heppner, Donald Gray; Gerlini, Alice; Kremsner, Peter Gottfried; Monath, Thomas; Ndungu, Francis; Njuguna, Patricia; Ottenhoff, Tom HM.; Pejoski, David; Page, Mark; Pozzi, Gianni; Santoro, Francesco; Dubey, Sheri; Fernandes, José F.; Lucchesi, Simone; Nakaya, Helder; Orourke, Fiona; Rothenberger, Sylvia; van Veen, Suzanne; Vianello, Eleonora
Published inClinical microbiology and infection, vol. 29, no. 12, p. 1587-1594
Publication date2023-09
Keywords
- Antibody avidity
- Antibody persistence
- Ebola virus disease
- Immunogenicity
- Neutralizing antibodies
- Vaccine
Citation (ISO format)
CSAKI HUTTNER, Angela et al. Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durability. In: Clinical microbiology and infection, 2023, vol. 29, n° 12, p. 1587–1594. doi: 10.1016/j.cmi.2023.08.026
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:174853
- DOI : 10.1016/j.cmi.2023.08.026
- PMID : 37661067
ISSN of the journal1198-743X
